Brief: Double Bond Pharmaceutical About To Sell Temodex In Latin America
28/09/2018 07:12
Sept 28 (Reuters) - Double Bond Pharmaceutical International
Ab (Publ) DBPHAb.TE :
* DOUBLE BOND PHARMACEUTICAL ABOUT TO SELL TEMODEX IN LATIN
AMERICA
* DISTRIBUTION WILL BE CARRIED OUT BY DOUBLE BOND
PHARMACEUTICALS
WHOLLY OWNED SUBSIDIARY DRUGSSON AB
Source text for Eikon: ID:nWkr7Qq0xj
Further company coverage: DBPHAb.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University